Loading company…
Sarcura develops an automated manufacturing platform for advanced cell therapies.
Sarcura combines silicon chip technology and microfluidics to control and manipulate cells during manufacturing. Its platform is intended to support therapies for metabolic and neurologic diseases. Founded in 2019, the company is based in Austria. It raised EUR 7 million in seed funding in November 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in